Relative strength of relationships of nasal congestion and ocular symptoms with sleep, mood and productivity

Current Medical Research and Opinion

Volumn 25, Issue 7, 2009, Pages 1785-1792

  Stull, Donald E ^a   Schaefer, Michael ^a   Crespi, Simone ^b   Sandor, David W ^b,c  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c Touro College and University System   (United States)

Author keywords

Allergic rhinitis; Nasal congestion; Ocular symptoms; Patient reported outcomes

Indexed keywords

ADULT; ALLERGIC RHINITIS; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EPIPHORA; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; NOSE CONGESTION; OCULAR PRURITUS; QUALITY OF LIFE; RHINOCONJUNCTIVITIS; SLEEP DISORDER; SOMNOLENCE; WORK DISABILITY;

ADOLESCENT; ADULT; AFFECT; AGED; AGED, 80 AND OVER; DATA COLLECTION; EFFICIENCY; EYE DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; OCCUPATIONAL HEALTH; QUALITY OF LIFE; RESPIRATION DISORDERS; RHINITIS, ALLERGIC, SEASONAL; SLEEP; SLEEP DISORDERS; WORKPLACE; YOUNG ADULT;

EID: 67650457572     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990903021968     Document Type: Article

References (24)

1. Stull DE, Roberts L, Frank L, et al. Relationship of nasal congestion with sleep, mood, and productivity. Curr Med Res Opin 2007;23:811-19
2. Storms W. Allergic rhinitis-induced nasal congestion: its impact on sleep quality. Prim Care Respir J 2008;17:7-18
3. Nathan RA. The burden of allergic rhinitis. Allergy Asthma Proc 2007;28:3-9
4. Gurevich F, Glass C, Hughes K, et al. Handling congestionrelated sleep disturbances in allergic rhinitis. J Respir Dis 2003; 24:178-84
5. Ferguson BJ. Influences of allergic rhinitis on sleep. Otolaryngol Head Neck Surg 2004;130:617-29
6. Alexander M, Patel P, Allegro S, Hicks A. Supplementation of fexofenadine therapy with nedocromil sodium 2% ophthalmic solution to treat ocular symptoms of seasonal allergic conjunctivitis. Clin Exp Ophthalmol 2003;31:206-12
7. Wallace DV, Dykewicz MS, Bernstein DI, et al.; Joint Task Force on Practice; American Academy of Allergy; Asthma & Immunology; American College of Allergy; Asthma, Immunology; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 2008; 122(2 Suppl):S1-84.
8. Spangler DL, Abelson MB, Ober A, et al. Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models. Clin Ther 2003;25:2245-67
9. Alexander M, Berger W, Buchholz P, et al. The reliability, validity, and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire (EAPIQ). Health Qual Life Outcomes 2005;3:67
10. Wood B. New treatments to relieve ocular allergies. Rev Optom 1999;136:124-35
11. Knight A. The role of levocabastine in the treatment of allergic rhinoconjunctivitis. Br J Clin Pract 1994;48:139-43
12. Pitt AD, Smith AF, Lindsell L, et al. Economic and quality-of-life impact of seasonal allergic conjunctivitis in Oxfordshire. Ophthalmic Epidemiol 2004;11:17-33
13. Ricard N, Kind P, Christian S, et al. Link between patient preferences and treatment outcomes in seasonal allergic rhinitis: an empiric investigation. Clin Ther 1999;21:268-77
14. Berger W, Abelson MB, Gomes PJ, et al. Effects of adjuvant therapy with 0.1% olopatadine hydrochloride ophthalmic solution on quality of life in patients with allergic rhinitis using systemic or nasal therapy. Ann Allergy Asthma Immunol 2005; 95:361-71
15. Bielory L. Allergic and immunologic disorders of the eye. Part II: ocular allergy. J Allergy Clin Immunol 2000;106:1019-32
16. Alexander M, Allegro S, Hicks A. Nedocromil sodium in golfers with seasonal allergic conjunctivitis. Adv Ther 2001;18:195-204
17. Pitt AD, Smith AF, Lindsell L, et al. Economic and quality-of-life impact of seasonal allergic conjunctivitis in Oxfordshire. Ophthalmic Epidemiol 2004;11:17-33
18. Bernstein DI, Levy AL, Hampel FC, et al. Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis. Clin Exp Allergy 2004;34:952-7
19. Juniper EF, Rohrbaugh T, Meltzer EO. A questionnaire to measure quality of life in adults with nocturnal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2003;111:484-90
20. Reilly MC, Tanner A, Meltzer EO. Work, classroom and activity impairment instruments: validation studies in allergic rhinitis. Clin Drug Invest 1996;11:278-88
21. Spritzer KL, Hays RD. MOS sleep scale: a manual for use and scoring. Santa Monica, CA: RAND Corporation, 2003
22. Hays RD, Martin SA, Sesti AM, Spritzer KL. Psychometric properties of the medical outcomes study sleep measure. Sleep Med 2005;6:41-4
23. Pratt EL, Craig TJ. Assessing outcomes from the sleep associated with rhinitis. Curr Opin Allergy Clin Immunol 2007;7:249-56
24. Watson D, Clark LA. The PANAS-X: Manual for the Positive and Negative Affect Schedule - Expanded Form. [unpublished manuscript] Iowa City, IA: The University of Iowa; 1999 [updated 1999 August; cited 2007 March 13]; 27]. Available from: http://www.psychology.uiowa.edu/Faculty/ Clark/PANAS-X.pdf.